Not logged in Long-term efficacy and safety of lorlatinib versus alectinib in anaplastic lymphoma kinase-positive advanced/metastatic non-small cell lung cancer: matching-adjusted indirect comparison Bauer, Todd; Abrahami, Devin; Polli, Anna; Chu, Haitao; Ramachandran, Priya; Chandler, Conor; Tan, Min; Truscott, James; Mazieres, Julien; Garcia, Christine A. Share Save
Kinetics and management of adverse events associated with lorlatinib after 5 years of follow-up in the CROWN study Liu, Geoffrey; Solomon, Benjamin J.; Mazieres, Julien; Kim, Dong-Wan; Cortinovis, Diego; Inoue, Takako; Sharma, Richu; Thurm, Holger; Polli, Anna; Bauer, Todd M. Share Save
Share Save
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study Bazhenova, Lyudmila; Kim, Dong-Wan; Cho, Byoung Chul; Goel, Sanjay; Heist, Rebecca; Werner, Theresa L.; Eaton, Keith D.; Wang, Judy S.; Pant, Shubham; Adkins, Douglas R.; Blakely, Collin M.; Yan, Xiaohong; Neuteboom, Saskia; Christensen, James G.; Chao, Richard; Bauer, Todd Share Save
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer Solomon, Benjamin J.; Liu, Geoffrey; Felip, Enriqueta; Mok, Tony S. K.; Soo, Ross A.; Mazieres, Julien; Shaw, Alice T.; de Marinis, Filippo; Goto, Yasushi; Wu, Yi-Long; Kim, Dong-Wan; Martini, Jean-Francois; Messina, Rossella; Paolini, Jolanda; Polli, Anna; Thomaidou, Despina; Toffalorio, Francesca; Bauer, Todd M. Share Save
Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial Solomon, Benjamin J.; Dagogo-Jack, Ibiayi; Lee, Se-Hoon; Boyer, Michael J.; Ramalingam, Suresh S.; Carcereny, Enric; Felip, Enriqueta; Han, Ji-Youn; Hida, Toyoaki; Hughes, Brett G. M.; Kim, Sang -We; Nishio, Makoto; Seto, Takashi; Okamoto, Tatsuro; Zhang, Xiaoxi; Martini, Jean -Francois; Wang, Erjian; De Beukelaer, Steven; Bauer, Todd M. Share Save
Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort Jonasch, Eric; Bauer, Todd M.; Papadopoulos, Kyriakos P.; Plimack, Elizabeth R.; Merchan, Jaime R.; Mcdermott, David F.; Michaelson, M. Dror; Appleman, Leonard J.; Roy, Ananya; Perini, Rodolfo F.; Liu, Yanfang; Choueiri, Toni K. Share Save
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors Bauer, Todd M.; Santoro, Armando; Lin, Chia-Chi; Garrido-Laguna, Ignacio; Joerger, Markus; Greil, Richard; Spreafico, Anna; Yau, Thomas; Goebeler, Maria-Elisabeth; Huetter-Kroenke, Marie Luise; Perotti, Antonella; Juif, Pierre-Eric; Lu, Darlene; Barys, Louise; Cremasco, Viviana; Pelletier, Marc; Evans, Helen; Fabre, Claire; Doi, Toshikiko Share Save
BRAF mutation status does not impact outcomes with tebentafusp in advanced cutaneous melanoma Shoushtari, A. N.; Middleton, M. R.; Hamid, O.; Meier, F.; Bauer, T.; Salama, A. K. S.; Kirkwood, J. M.; Ascierto, P. A.; Lorigan, P.; Mauch, C.; Orloff, M.; Edukulla, R.; Goodall, H.; Hassel, J. C.; Evans, T. R. J. Share Save
Phase II LITESPARK-003 study of belzutifan in combination with cabozantinib for advanced clear cell renal cell carcinoma (ccRCC) Choueiri, T. K.; Bauer, T.; Merchan, J. R.; McDermott, D. F.; Figlin, R.; Arrowsmith, E.; Michaelson, M. D.; Heath, E.; D'Souza, A. A.; Zhao, S.; Mhamdi, L.; Perini, R.; Vickery, D.; Tykodi, S. Share Save
First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma Hamilton, Erika P.; Wang, Judy S.; Oza, Amit M.; Patel, Manish R.; Ulahannan, Susanna V.; Bauer, Todd; Karlix, Janet L.; Zeron-Medina, Jorge; Fabbri, Giulia; Marco-Casanova, Paola; Moorthy, Ganesh; Hattersley, Maureen M.; Littlewood, Gillian M.; Mitchell, Patrick; Saeh, Jamal; Pouliot, Gayle P.; Moore, Kathleen N. Share Save
Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer Solomon, Benjamin J.; Bauer, Todd M.; Mok, Tony S. K.; Liu, Geoffrey; Mazieres, Julien; de Marinis, Filippo; Goto, Yasushi; Kim, Dong-Wan; Wu, Yi-Long; Jassem, Jacek; Lopez, Froylan Lopez; Soo, Ross A.; Shaw, Alice T.; Polli, Anna; Messina, Rossella; Iadeluca, Laura; Toffalorio, Francesca; Felip, Enriqueta Share Save
Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study Hamid, Omid; Hassel, Jessica C.; Shoushtari, Alexander N.; Meier, Friedegund; Bauer, Todd M.; Salama, April K. S.; Kirkwood, John M.; Ascierto, Paolo A.; Lorigan, Paul C.; Mauch, Cornelia; Orloff, Marlana; Evans, Thomas R. Jeffry; Holland, Chris; Edukulla, Ramakrishna; Abedin, Shaad E.; Middleton, Mark R. Share Save
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors Bauer, Todd M.; Moore, Kathleen N.; Rader, Janet S.; Simpkins, Fiona; Mita, Alain C.; Beck, J. Thaddeus; Hart, Lowell; Chu, Quincy; Oza, Amit; Tinker, Anna V.; Imedio, Esteban Rodrigo; Kumar, Sanjeev; Mugundu, Ganesh; Jenkins, Suzanne; Chmielecki, Juliann; Jones, Suzanne; Spigel, David; Fu, Siqing Share Save
The MDM2-p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study LoRusso, Patricia; Yamamoto, Noboru; Patel, Manish R.; Laurie, Scott A.; Bauer, Todd M.; Geng, Junxian; Davenport, Teffany; Teufel, Michael; Li, Jian; Lahmar, Mehdi; Gounder, Mrinal M. Share Save
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study Solomon, Benjamin J.; Bauer, Todd M.; Mok, Tony S. K.; Liu, Geoffrey; Mazieres, Julien; de Marinis, Filippo; Goto, Yasushi; Kim, Dong-Wan; Wu, Yi-Long; Jassem, Jacek; Lopez, Froylan Lopez; Soo, Ross A.; Shaw, Alice T.; Polli, Anna; Messina, Rossella; Iadeluca, Laura; Toffalorio, Francesca; Felip, Enriqueta Share Save
Long-term intracranial safety and efficacy analyses from the phase III CROWN study Bearz, A.; Felip, E.; Mazieres, J.; de Marinis, F.; Bauer, T.; Polli, A.; Messina, R.; Thurm, H.; Thomaidou, D.; Mok, T. S. K.; Solomon, B. J. Share Save
Share Save
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors Lim, Emerson A.; Bendell, Johanna C.; Falchook, Gerald S.; Bauer, Todd M.; Drake, Charles G.; Choe, Jennifer H.; George, Daniel J.; Karlix, Janet L.; Ulahannan, Susanna; Sachsenmeier, Kris F.; Russell, Deanna L.; Moorthy, Ganesh; Sidders, Ben S.; Pilling, Elizabeth A.; Chen, Huifang; Hattersley, Maureen M.; Das, Mayuk; Kumar, Rakes; Pouliot, Gayle P.; Patel, Manish R. Share Save
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors Bauer, Todd; Cho, Byong Chul; Heist, Rebecca; Bazhenova, Lyudmila; Werner, Theresa; Goel, Sanjay; Kim, Dong-Wan; Adkins, Douglas; Carvajal, Richard D.; Alva, Ajjai; Eaton, Keith; Wang, Judy; Liu, Yong; Yan, Xiaohong; Christensen, Jamie; Neuteboom, Saskia; Chao, Richard; Pant, Shubham Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
